Skip to content

Advertisement

BMC Urology

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer

  • Avelino Fraga1, 2, 3Email author,
  • Ricardo Ribeiro2, 4, 5,
  • André Coelho6,
  • José Ramon Vizcaíno6,
  • Helena Coutinho7,
  • José Manuel Lopes7, 8,
  • Paulo Príncipe1, 2,
  • Carlos Lobato9,
  • Carlos Lopes3 and
  • Rui Medeiros3, 4
BMC UrologyBMC series – open, inclusive and trusted201717:12

https://doi.org/10.1186/s12894-017-0201-y

Received: 6 October 2016

Accepted: 10 January 2017

Published: 31 January 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
6 Oct 2016 Submitted Original manuscript
18 Oct 2016 Reviewed Reviewer Report - Donna Ankerst
25 Oct 2016 Reviewed Reviewer Report - Michael O'Callaghan
29 Oct 2016 Reviewed Reviewer Report - Elmar Heinrich
27 Nov 2016 Author responded Author comments - AVELINO FRAGA
Resubmission - Version 2
27 Nov 2016 Submitted Manuscript version 2
14 Dec 2016 Author responded Author comments - AVELINO FRAGA
Resubmission - Version 3
14 Dec 2016 Submitted Manuscript version 3
Publishing
10 Jan 2017 Editorially accepted
31 Jan 2017 Article published 10.1186/s12894-017-0201-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Urology, Porto Hospital Centre – St. António Hospital
(2)
Center for Urological Research, Department of Urology, Porto Hospital Centre – St. António Hospital
(3)
ICBAS, Abel Salazar Biomedical Sciences Institute, University of Porto
(4)
Molecular Oncology Group - CI, Portuguese Institute of Oncology
(5)
Genetics Laboratory, Faculty of Medicine, University of Lisbon
(6)
Department of Pathology, Porto Hospital Centre – St. António Hospital
(7)
Department of Pathology and Oncology, Faculty of Medicine, University of Porto
(8)
Institute of Pathology and Molecular Immunology of University of Porto (IPATIMUP)
(9)
Department of Urology, Porto Military Hospital

Advertisement